PROGNOSTIC IMPACT OF REDUCED HER2 PROTEIN EXPRESSION IN POST-NEOADJUVANT THERAPY RESECTION SPECIMENS: A SINGLE INSTITUTION EXPERIENCE AND REVIEW OF THE LITERATURE

Prognostic impact of reduced HER2 protein expression in post-neoadjuvant therapy resection specimens: A single institution experience and review of the literature

Background: Retesting for voyage et cie discount code Human epidermal growth factor receptor-2 (HER2) in post-neoadjuvant therapy resection is variable, and data is conflicting regarding the prognostic significance of changes in HER2 expression pre and post therapy.Methods: We identified 104 patients with localized HER2 IHC 3+ breast cancer who rec

read more